Proteome Sciences (LSE:PRM) FCF Margin %: 42.76% (As of Dec. 2025)


What is Proteome Sciences FCF Margin %?

Proteome Sciences LSE:PRM +11.92% FCF Margin % is 42.76% as of Dec. 2025. The stock has 6 warning signs investors should review. Among 204 Medical Diagnostics & Research companies, Proteome Sciences ranks worse than 53.92% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Proteome Sciences's Free Cash Flow for the six months ended in Dec. 2025 was £0.81 Mil. Proteome Sciences's Revenue for the six months ended in Dec. 2025 was £1.90 Mil. Therefore, Proteome Sciences's FCF Margin % for the quarter that ended in Dec. 2025 was 42.76%.

As of today, Proteome Sciences's current FCF Yield % is -2.41%.

The historical rank and industry rank for Proteome Sciences's FCF Margin % or its related term are showing as below:

LSE:PRM' s FCF Margin % Range Over the Past 10 Years
Min: -73.87   Med: -9.05   Max: 33.03
Current: -3.81

During the past 13 years, the highest FCF Margin % of Proteome Sciences was 33.03%. The lowest was -73.87%. And the median was -9.05%.

LSE:PRM's FCF Margin % is ranked worse than
53.92% of 204 companies
in the Medical Diagnostics & Research industry
Industry Median: -1.845 vs LSE:PRM: -3.81

Proteome Sciences FCF Margin % Related Terms

Proteome Sciences FCF Margin % Historical Data

* Premium members only.

The historical data trend for Proteome Sciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proteome Sciences FCF Margin % Chart

Proteome Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.48 23.41 -14.28 -21.49 -3.81

Proteome Sciences Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -88.61 -23.59 -19.74 -51.43 42.76

LSE:PRM vs TMO, DHR, IDXX: FCF Margin % Comparison

For the Diagnostics & Research subindustry, Proteome Sciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Proteome Sciences FCF Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Proteome Sciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Proteome Sciences's FCF Margin % falls into.


Proteome Sciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Proteome Sciences's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-0.143/3.756
=-3.81 %

Proteome Sciences's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=0.812/1.899
=42.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 42.76% mean?
Proteome Sciences (LSE:PRM) has a FCF Margin % of 42.76% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Proteome Sciences and its competitors. According to the industry distribution chart, Proteome Sciences ranks #110 out of 204 companies in the Medical Diagnostics & Research industry, placing it in the top 53.9%.
Is Proteome Sciences' FCF Margin % too high?
Proteome Sciences' current FCF Margin % is 42.76%. Based on the distribution chart, Proteome Sciences ranks #110 out of 204 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint.
How does Proteome Sciences' FCF Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Proteome Sciences ranks #110 out of 204 companies for FCF Margin %. This places Proteome Sciences in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Diagnostics & Research company?
A good FCF Margin % depends on the Medical Diagnostics & Research industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Proteome Sciences and its competitors. Proteome Sciences's current FCF Margin % is 42.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteome Sciences stock overvalued right now?
Based on GuruFocus' analysis, Proteome Sciences (LSE:PRM) is currently considered Modestly Undervalued. The stock's GF Value™ is £0.02, compared to a current price of £0.02 — trading 15.5% below its estimated fair value. The current FCF Margin % is 42.76%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Proteome Sciences (LSE:PRM), the current FCF Margin % is 42.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Proteome Sciences Business Description

Other Exchanges PRMl:UKPI2:Germany
Address Downside Bridge Road, Coveham House, Cobham, Surrey, GBR, KT11 3EP
Proteome Sciences PLC is engaged in protein biomarker research and development. The company is a provider of contract research services for the identification, validation and application of protein biomarkers. The company's only reportable segment is the sale of goods and biomarker services. The company generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Others.